Time course of histological progression in primary biliary cirrhosis

Histological staging is used for stratification and assessment of treatment efficacy in therapeutic trials for primary biliary cirrhosis (PBC). Knowledge of the rate of progression of the histological changes would be helpful in the design (duration) and conduct of clinical trials. The histological stages were recorded for liver biopsies performed annually on 222 patients during a randomized, placebo‐ controlled clinical trial in which therapy with D‐penicillamine (DPCA) was shown to be ineffective. These data were analyzed using a Markov model to describe the time course of histological progression in PBC. At study entry, 15 patients were stage I, 56 were stage II, 96 were stage III, and 55 were stage IV. Histological progression was observed after 1 year in 41%, 43%, and 35% of the patients, and after 2 years in 62%, 62%, and 50% of the patients who were stage I, stage II, and stage III at entry, respectively. After 4 years biopsies showed cirrhosis in 31% and 50% of the patients in stage I and stage II at entry, respectively. A minority (20%) of the precirrhotic patients showed histological stability; sustained histological regression was rarely observed (2%). Our data suggest that a majority of patients with PBC will progress histologically within 2 years. The distribution of histological stages over time may be helpful in determining the number of patients and length of time necessary to appreciate a treatment effect on histological progression in clinical trials for PBC.

[1]  B. Taal,et al.  Low therapeutic value of D-penicillamine in a short-term prospective trial in primary biliary cirrhosis. , 2008, Liver.

[2]  Charles E. Kahn,et al.  primary biliary cirrhosis , 1995 .

[3]  E. Dickson,et al.  Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. , 1994, Gastroenterology.

[4]  U. Steinbrecher,et al.  The canadian multicenter double‐blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis , 1994, Hepatology.

[5]  Niels Keiding,et al.  Statistical Models Based on Counting Processes , 1993 .

[6]  M. Kaplan,et al.  Treatment of primary biliary cirrhosis with low-dose weekly methotrexate. , 1991, Gastroenterology.

[7]  B. Balkau,et al.  A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. , 1991, The New England journal of medicine.

[8]  E. Dickson,et al.  A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis. , 1990, The New England journal of medicine.

[9]  P. Grambsch,et al.  Extramural cross‐validation of the mayo primary biliary cirrhosis survival model establishes its generalizability , 1989, Hepatology.

[10]  P. Grambsch,et al.  Prognosis in primary biliary cirrhosis: Model for decision making , 1989, Hepatology.

[11]  F. Schaffner,et al.  Evaluation of colchicine therapy in primary biliary cirrhosis. , 1988, Gastroenterology.

[12]  M. Kaplan,et al.  A prospective trial of colchicine for primary biliary cirrhosis. , 1986, The New England journal of medicine.

[13]  J. Hoofnagle,et al.  Randomized trial of chlorambucil for primary biliary cirrhosis. , 1986, Gastroenterology.

[14]  F. Klion,et al.  A prospective clinical trial of D‐penicillamine in the treatment of primary biliary cirrhosis , 1985, Hepatology.

[15]  D. Altman,et al.  Beneficial Effect of Azathioprine and Prediction of Prognosis in Primary Biliary , 1985 .

[16]  J. Neuberger,et al.  Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients. , 1985, Gastroenterology.

[17]  T R Fleming,et al.  Trial of penicillamine in advanced primary biliary cirrhosis. , 1985, The New England journal of medicine.

[18]  N Tygstrup,et al.  Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis. , 1985, Gut.

[19]  J. Boyer,et al.  The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. , 1983, The New England journal of medicine.

[20]  M. Kaplan,et al.  A prospective trial of D-penicillamine in primary biliary cirrhosis. , 1982, The New England journal of medicine.

[21]  S. Sherlock,et al.  D-PENICILLAMINE TREATMENT IMPROVES SURVIVAL IN PRIMARY BILIARY CIRRHOSIS , 1981, The Lancet.

[22]  E. Christensen,et al.  Azathioprine in primary biliary cirrhosis: a preliminary report of an international trial. , 1980, Gastroenterology.

[23]  E. Christensen,et al.  Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients , 1980 .

[24]  S. Sherlock,et al.  A prospective controlled trial of azathioprine in primary biliary cirrhosis. , 1976, Gastroenterology.

[25]  A. T. Bharucha-Reid.  Elements of the theory of Markov processes and their applications , 1961 .

[26]  B. Efron.  The jackknife, the bootstrap, and other resampling plans , 1987 .

[27]  P. Scheuer,et al.  Liver Biopsy Interpretation , 1973 .

[28]  H. Popper,et al.  Nonsuppurative destructive chronic cholangitis and chronic hepatitis. , 1970, Progress in liver diseases.